RUSNE DRAZ LIMITED

Company number 14458106 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

RUSNE DRAZ LIMITED - Analysis Report

Company Number: 14458106

Analysis Date: 2025-07-29 12:10 UTC

Financial Health Score: B

Key Vital Signs:

  • Net Assets: £58,680 — Indicates positive equity and a buffer against liabilities, showing healthy capital structure.
  • Net Current Assets (Working Capital): £44,153 — A strong positive working capital suggests the company has sufficient short-term liquidity to meet its obligations.
  • Fixed Assets: £14,527 — Represents investment in long-term resources, demonstrating some asset base.
  • Current Liabilities: £32,540 — Manageable given the level of current assets and net current assets.
  • Employee Count: 1 — Reflects a micro-business scale, limiting complexity and overheads.

Symptoms Analysis: The balance sheet shows "healthy cash flow" indicators through a solid working capital position, meaning the company is not under short-term financial stress. The net assets being positive and significantly above zero indicate no immediate solvency concerns—the company has more assets than liabilities, a key "vital sign" of financial viability.

The micro-entity status and single employee indicate a small-scale operation, which typically comes with lower financial complexity and risk, but also limited capacity for rapid growth or diversification. The absence of audit requirements and exemptions under the Companies Act 2006 suggest streamlined compliance but also limited publicly available financial disclosures.

Diagnosis: RUSNE DRAZ LIMITED is financially stable with a sound balance sheet and adequate liquidity to cover its short-term liabilities. The company’s financial "vital signs" do not show symptoms of distress such as negative working capital, high debt levels, or net losses. The sole director and shareholder structure centralizes decision-making, which can be agile but may expose the company to "single point of failure" risk.

Prognosis: Given current data, the company’s outlook is cautiously positive. Maintaining the strong working capital and net asset position will be crucial. However, growth prospects may be constrained by the micro-entity scale and limited staffing. Monitoring cash flow and liabilities will be important to prevent future liquidity "symptoms" that could arise from expanding operations or unforeseen expenses.

Recommendations:

  1. Continue rigorous cash flow management to sustain healthy working capital, ensuring timely payment of current liabilities.
  2. Consider formalizing financial planning and budgeting, even at micro-entity scale, to anticipate future capital needs.
  3. Evaluate opportunities to increase fixed assets prudently to support potential growth without overextending financially.
  4. Strengthen governance by possibly involving additional directors or advisors to diversify strategic input and reduce concentration risk.
  5. Maintain compliance with filing deadlines and regulatory requirements to avoid penalties and preserve company reputation.
  6. Explore market opportunities within photographic activities to leverage existing assets and expertise for revenue growth.

Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 29 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.